NextCure
NXTC
NXTC
78 hedge funds and large institutions have $122M invested in NextCure in 2021 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 20 increasing their positions, 33 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
32% less capital invested
Capital invested by funds: $180M → $122M (-$57.8M)
39% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 33
50% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 28
Holders
78
Holding in Top 10
1
Calls
$1.71M
Puts
$1.08M
Top Buyers
| 1 | +$4.1M | |
| 2 | +$2.52M | |
| 3 | +$2.41M | |
| 4 |
NAM
Nexpoint Asset Management
Dallas,
Texas
|
+$1.89M |
| 5 |
Renaissance Technologies
New York
|
+$1.61M |
Top Sellers
| 1 | -$7.66M | |
| 2 | -$5.64M | |
| 3 | -$4.5M | |
| 4 |
Morgan Stanley
New York
|
-$3.23M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$2.8M |